Adjuvant Ipilimumab in High-Risk Uveal Melanoma

Uveal melanoma is a common intraocular malignant tumor that is uniformly fatal once metastatic. No effective adjuvant therapy currently exists to reduce the risk of distant metastasis after definitive treatment of the primary lesion. Immunotherapy has been used effectively in the adjuvant setting in...

Descripción completa

Detalles Bibliográficos
Autores principales: Fountain, Eric, Bassett, Roland L., Cain, Suzanne, Posada, Liberty, Gombos, Dan S., Hwu, Patrick, Bedikian, Agop, Patel, Sapna P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406862/
https://www.ncbi.nlm.nih.gov/pubmed/30699934
http://dx.doi.org/10.3390/cancers11020152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406862/
https://www.ncbi.nlm.nih.gov/pubmed/30699934
http://dx.doi.org/10.3390/cancers11020152

Ejemplares similares